Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 1295-1299, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koch, T. R.
Right arrow Articles by Akingbe, O. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koch, T. R.
Right arrow Articles by Akingbe, O. O.

Clinical Chemistry, Vol 27, 1295-1299, Copyright © 1981 by American Association for Clinical Chemistry

Feasibility of measuring free and total bilirubin electrochemically in serum

TR Koch and OO Akingbe

Bilirubin undergoes irreversible reduction at the hanging-mercury-drop electrode in tris(hydroxymethyl)methylamine buffer (0.1 mol/L, pH 8.5). Peak current is linearly related to concentration in the range 0-1 mg/L. The half-wave potential of -1.32 V vs the saturated calomel electrode is little affected by pH, whereas peak current increases with pH to pH 9.5, then decreases rapidly. Exposing the test solution to light causes the peak current to decline at a rate proportional to concentration. Albumin-bound bilirubin is electrochemically inactive, so free bilirubin can be measured in the presence of bilirubin- saturated albumin. Serum total bilirubin can be measured after much of the protein is precipitated by adding methanol. Results for serum bilirubin as measured electrochemically (y) in 20 methanolic filtrates of serum compared well with the Jendrassik-Grof Method (x) in preliminary studies: y = 0.981x -0.311; r = 0.9716. We discuss the possible mechanism of the reduction process and potential clinical applications. Polarographic measurement of bilirubin and bilirubin- binding capacity is feasible and may be advantageous as compared with existing techniques.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.